Search

everythinglearnresearchcommunity

for

Search:↓

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Men with androgenetic alopecia may have a higher risk of metabolic syndrome.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Hair loss may increase heart disease risk.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Chitosan-coated nanoparticles can effectively deliver positively charged drugs through the skin using iontophoresis.

N-oxides are important in medicine for improving drug properties and targeting.

Standardized guidelines are needed to improve drug-loaded extracellular vesicle purification.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

Extracellular vesicles could help tailor drug treatments, but more research is needed.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Microneedles are promising for disease monitoring and drug delivery due to their minimal invasiveness and versatility.

The intestinal lymphatic system is active and promising for targeted drug delivery and therapies.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Cepharanthine shows promise as a COVID-19 treatment.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Certain medications, especially 5-α reductase inhibitors and neuropsychiatric drugs, are often linked to erectile dysfunction.

A new wearable system improves wound healing by monitoring infections and delivering precise treatment.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Combining plant extracts with nanotechnology may improve hair loss treatments.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.